Skip to main content

Table 2 Metabolic and other laboratory assessments of 156 perinatally HIV-infected South African children at the final study visit of Neverest 2 by sex within treatment randomization group

From: Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment

Measurement

LPV/r (n = 85)

 

NVP (n = 71)

 
  

Boys (n = 41)

Girls (n = 44)

P-value

Boys (n = 40)

Girls (n = 31)

P-value

Total Cholesterol, mg/dL

Mean (SD)

170 (39)

172 (39)

0.816

163 (25)

159 (38)

0.533

 Acceptable: <170

N (%)

24 (58.5)

21 (47.7)

0.603

29 (72.5)

23 (74.2)

0.884

 Borderline: 170-199

10 (24.4)

14 (31.8)

8 (20.0)

5 (16.1)

 Elevated: ≥200

7 (17.1)

9 (20.5)

3 (7.5)

3 (9.7)

HDL, mg/dL

Mean (SD)

54 (14)

48 (12)

0.044

60 (15)

57 (16)

0.352

 Abnormal: <35

N (%)

2 (4.9)

5 (11.4)

0.277

0 (0.0)

2 (6.4)

0.103

 Normal: ≥35

39 (95.1)

39 (88.6)

40 (100.0)

29 (93.6)

LDL, mg/dL

Mean (SD)

98 (31)

101 (38)

0.664

89 (24)

87 (29)

0.738

 Acceptable: <110

N (%)

28 (68.3)

28 (63.6)

0.895

31 (77.5)

25 (80.7)

0.516

 Borderline: 110-129

7 (17.1)

9 (20.5)

7 (17.5)

3 (9.7)

 Elevated: ≥130

6 (14.6)

7 (15.9)

2 (0.5)

3 (9.7)

Total Cholesterol: HDL Ratio

Mean (SD)

3.3 (1.0)

3.8 (1.1)

0.049

2.8 (0.7)

3.0 (1.0)

0.547

Triglycerides, mg/dL

Mean (SD)

88 (34)

99 (42)

0.207

69 (27)

74 (32)

0.457

 Normal: ≤150

N (%)

37 (90.2)

37 (84.1)

0.398

39 (97.5)

30 (96.8)

0.855

 Abnormal: >150

4 (9.8)

7 (15.9)

1 (2.5)

1 (3.2)

C-Reactive Protein, mg/L

Mean (SD)

3.2 (5.6)

3.8 (6.5)

0.453

9.5 (23.8)

9.8 (18.1)

0.423

 Normal: ≤3

N (%)

33 (80.5)

36 (81.8)

0.875

27 (67.5)

19 (61.3)

0.587

 Elevated: >3

8 (19.5)

8 (18.2)

13 (32.5)

12 (38.7)

Glucose, mg/dL

Mean (SD)

96.9 (7.1)

96.4 (7.8)

0.736

97.6 (9.2)

93.7 (8.5)

0.070

 Normal: <110

N (%)

80 (98.8)

41 (100.0)

0.332

74 (98.7)

39 (97.5)

0.375

 Impaired: ≥110

1 (1.2)

0 (0.0)

1 (1.3)

1 (2.5)

HOMA-IR

Mean (SD)

0.90 (0.5)

1.16 (0.6)

0.036

1.17 (1.0)

0.96 (0.6)

0.289

 Normal: ≤3.16

N (%)

41 (100.0)

44 (100.0)

1.0

36 (92.3)

31 (100.0)

0.115

 Resistance: >3.16

 

0 (0.0)

0 (0.0)

 

3 (7.7)

0 (0.0)

 
  1. Abbreviations: LPV/r Lopinavir-boosted ritonavir, NVP Nevirapine, HDL High-density lipoprotein, LDL Low-density lipoprotein, HOMA-IR Homeostatic model assessment of insulin resistance.